NCT02679378 - Exploratory Study Comparing ClearSight System 2D Map to Post Surgery Histopathological Analysis in Lumpectomy | Biotech Hunter

Enrollment

220

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

November 30, 2018

Conditions

Breast Cancer

Interventions

DEVICE

ClearSight™ System

comparing ClearSight system to histopathological to determine negative-margins in breast conserving surgery.

Trial Locations (5)

The George Washington University Hospital (GWU), Washington D.C.

University of Arkansas for Medical Sciences, Little Rock

Kaplan Medical Center, Rehovot

Assuta Medical Center, Tel Aviv

Assaf Harofeh Medical Center, Ẕerifin